Artrya (ASX:AYA) is the latest Aussie biotech stock to score an FDA approval and consequent rewarding share price jump from ...

Shares of Soleno Therapeutics SLNO have rallied 37% in the premarket hours today following the FDA approval of Vykat XR ...

One scientist at the FDA's Center for Tobacco Products said the center had delayed starting new applications while staff ...

PathChat, a new AI model for pathology made by Modella AI, received breakthrough status in January. The device can digest ...

Soleno on Wednesday said the FDA approved its Vykat XR extended-release tablets for the treatment of hyperphagia, a chronic and life-threatening feeling of intense, persistent hunger, in people ages 4 ...

Soleno Therapeutics (SLNO) “announced that the FDA has approved VYKAT XR, diazoxide choline, extended-release tablets, previously referred to ...

The Food and Drug Administration (FDA) has approved a new drug for treating urinary tract infections, the first such drug ...

First approved therapy to address hyperphagia in individuals with Prader-Willi syndromeManagement to host conference call and webcast today, ...

(Reuters) -The U.S. Food and Drug Administration on Wednesday approved Soleno Therapeutics' drug to treat a rare genetic ...

A decision on tolebrutinib for treating MS is now set for Sept. 28, after the FDA granted priority review to its approval ...

Makary earlier this month distanced himself from the recent shake-ups at the FDA, including the cancellation of its vaccines ...